Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BerGenBio AGM Information 2019

Mar 13, 2019

3555_rns_2019-03-13_9a0e2824-5999-4a52-afcb-aad4bab5c912.html

AGM Information

Open in viewer

Opens in your device viewer

BerGenBio ASA: Annual general meeting

BerGenBio ASA: Annual general meeting

Bergen, Norway, 13 March 2019 – Annual general meeting of BerGenBio ASA was held at Clarion Hotel Bergen Airport, Flyplassveien 551, 5869 Bergen, on 13 March 2019.

All proposals were resolved as presented in the notice convening the annual general meeting distributed on 20 February 2019, as further set out in the minutes from the annual general meeting attached hereto and available at https://www.bergenbio.com/investors/general-meetings/.

For further information, please contact:

Richard Godfrey

CEO, BerGenBio ASA

[email protected]

Rune Skeie

CFO, BerGenBio ASA

[email protected]

+47 917 86 513

Forward looking statements

This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements.

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.